ROYAL BANK OF CANADA - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 147 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$2,120,000
-18.6%
61,571
-60.5%
0.00%0.0%
Q2 2020$2,605,000
+14.8%
155,924
-0.9%
0.00%0.0%
Q1 2020$2,269,000
-58.7%
157,302
-4.3%
0.00%
-50.0%
Q4 2019$5,500,000
+54.9%
164,333
-3.1%
0.00%
+100.0%
Q3 2019$3,550,000
+31.4%
169,556
+30.7%
0.00%0.0%
Q2 2019$2,702,000
+2.7%
129,778
+10.3%
0.00%0.0%
Q1 2019$2,631,000
+25.3%
117,679
+34.2%
0.00%0.0%
Q4 2018$2,099,000
-1.0%
87,716
+12.8%
0.00%0.0%
Q3 2018$2,121,000
+341.9%
77,777
+335.1%
0.00%
Q2 2018$480,000
-13.5%
17,876
+2.4%
0.00%
Q1 2018$555,000
+3600.0%
17,463
+4412.4%
0.00%
Q4 2017$15,000
-81.5%
387
-88.2%
0.00%
Q3 2017$81,000
+8000.0%
3,269
+4038.0%
0.00%
Q2 2017$1,000
-94.7%
79
-90.4%
0.00%
Q1 2017$19,000
-57.8%
826
-62.4%
0.00%
Q4 2016$45,000
+4400.0%
2,199
+2581.7%
0.00%
Q3 2016$1,00082
+310.0%
0.00%
Q4 2015$0
-100.0%
20
-95.0%
0.00%
Q3 2015$10,0004000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Aisling Capital LLC 1,240,000$25,966,00057.34%
Foresite Capital Management II, LLC 2,605,499$54,559,00011.53%
Foresite Capital Management III, LLC 611,893$12,813,0004.89%
Palo Alto Investors LP 3,471,740$72,698,0004.84%
SANDERS MORRIS HARRIS LLC 486,906$10,196,0002.47%
Eventide Asset Management 3,084,000$64,579,0002.13%
Sofinnova Investments, Inc. 346,770$7,261,0000.66%
EMERALD ADVISERS, LLC 610,511$12,784,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 752,358$15,754,0000.56%
EMERALD MUTUAL FUND ADVISERS TRUST 587,464$12,301,0000.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders